Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 2Exercise 2Bariatric Surgery 2semaglutide 1mirogabalin 1exemestane 1Standard of Care 1Sex Education 1Resistance Training 1Progestins 1Patient Navigation 1Oxycodone 1Nutrition Assessment 1Mindfulness 1Metformin 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Low-Level Light Therapy 1Leuprolide 1Letrozole 1Hysteroscopy 1Hepatectomy 1Goserelin 1Gonadotropin-Releasing Hormone 1Fecal Microbiota Transplantation 1Estrogen Replacement Therapy 1Duloxetine Hydrochloride 1Diet Therapy 1Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Estrogen Replacement Therapy × Other × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡